US pharma patent plans come under attack
A WIPO meeting on patent law last week saw the US put forward a proposal regarding the availability of medicines in the developing world. Although its suggestions do not contain anything shocking or surprising, criticism of the plans shows that this…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.